Updated European Consensus Statement on diagnosis and treatment of adult ADHD

J. J.S. Kooij; D. Bijlenga; L. Salerno; R. Jaeschke; I. Bitter; J. Balázs; J. Thome; G. Dom; S. Kasper; C. Nunes Filipe; S. Stes; P. Mohr; S. Leppämäki; M. Casas Brugué; J. Bobes; J. M. Mccarthy; V. Richarte; A. Kjems Philipsen; A. Pehlivanidis; A. Niemela; B. Styr; B. Semerci; B. Bolea-Alamanac; D. Edvinsson; D. Baeyens; D. Wynchank; E. Sobanski; A. Philipsen; F. McNicholas; H. Caci; I. Mihailescu; I. Manor; I. Dobrescu; J. Krause; J. Fayyad; J. A. Ramos-Quiroga; K. Foeken; F. Rad; M. Adamou; M. Ohlmeier; M. Fitzgerald; M. Gill; M. Lensing; N. Motavalli Mukaddes; P. Brudkiewicz; P. Gustafsson; P. Tani; P. Oswald; P. J. Carpentier; P. De Rossi; R. Delorme; S. Markovska Simoska; S. Pallanti; S. Young; S. Bejerot; T. Lehtonen; J. Kustow; U. Müller-Sedgwick; T. Hirvikoski; V. Pironti; Y. Ginsberg; Z. Félegeházy; M. P. Garcia-Portilla; P. Asherson

doi:10.1016/j.eurpsy.2018.11.001

Updated European Consensus Statement on diagnosis and treatment of adult ADHD

J. J.S. Kooij, D. Bijlenga, L. Salerno, R. Jaeschke, I. Bitter, J. Balázs, J. Thome, G. Dom, S. Kasper, C. Nunes Filipe, S. Stes, P. Mohr, S. Leppämäki, M. Casas Brugué, J. Bobes, J. M. Mccarthy, V. Richarte, A. Kjems Philipsen, A. Pehlivanidis, A. NiemelaB. Styr, B. Semerci, B. Bolea-Alamanac, D. Edvinsson, D. Baeyens, D. Wynchank, E. Sobanski, A. Philipsen, F. McNicholas, H. Caci, I. Mihailescu, I. Manor, I. Dobrescu, J. Krause, J. Fayyad, J. A. Ramos-Quiroga, K. Foeken, F. Rad, M. Adamou, M. Ohlmeier, M. Fitzgerald, M. Gill, M. Lensing, N. Motavalli Mukaddes, P. Brudkiewicz, P. Gustafsson, P. Tani, P. Oswald, P. J. Carpentier, P. De Rossi, R. Delorme, S. Markovska Simoska, S. Pallanti, S. Young, S. Bejerot, T. Lehtonen, J. Kustow, U. Müller-Sedgwick, T. Hirvikoski, V. Pironti, Y. Ginsberg, Z. Félegeházy, M. P. Garcia-Portilla, P. Asherson

Research output: Contribution to journal › Article › peer-review

405 Scopus citations

Abstract

Background Attention-deficit/hyperactivity disorder (ADHD) is among the most common psychiatric disorders of childhood that often persists into adulthood and old age. Yet ADHD is currently underdiagnosed and undertreated in many European countries, leading to chronicity of symptoms and impairment, due to lack of, or ineffective treatment, and higher costs of illness. Methods The European Network Adult ADHD and the Section for Neurodevelopmental Disorders Across the Lifespan (NDAL) of the European Psychiatric Association (EPA), aim to increase awareness and knowledge of adult ADHD in and outside Europe. This Updated European Consensus Statement aims to support clinicians with research evidence and clinical experience from 63 experts of European and other countries in which ADHD in adults is recognized and treated. Results Besides reviewing the latest research on prevalence, persistence, genetics and neurobiology of ADHD, three major questions are addressed: (1) What is the clinical picture of ADHD in adults? (2) How should ADHD be properly diagnosed in adults? (3) How should adult ADHDbe effectively treated? Conclusions ADHD often presents as a lifelong impairing condition. The stigma surrounding ADHD, mainly due to lack of knowledge, increases the suffering of patients. Education on the lifespan perspective, diagnostic assessment, and treatment of ADHD must increase for students of general and mental health, and for psychiatry professionals. Instruments for screening and diagnosis of ADHD in adults are available, as are effective evidence-based treatments for ADHD and its negative outcomes. More research is needed on gender differences, and in older adults with ADHD.

Original language	English
Pages (from-to)	14-34
Number of pages	21
Journal	European Psychiatry
Volume	56
DOIs	https://doi.org/10.1016/j.eurpsy.2018.11.001
State	Published - Feb 2019
Externally published	Yes

Keywords

Adult ADHD
Diagnosis
EPA
European Network Adult ADHD
Treatment
Updated European Consensus Statement

Access to Document

10.1016/j.eurpsy.2018.11.001

Cite this

Kooij, J. J. S., Bijlenga, D., Salerno, L., Jaeschke, R., Bitter, I., Balázs, J., Thome, J., Dom, G., Kasper, S., Nunes Filipe, C., Stes, S., Mohr, P., Leppämäki, S., Casas Brugué, M., Bobes, J., Mccarthy, J. M., Richarte, V., Kjems Philipsen, A., Pehlivanidis, A., ... Asherson, P. (2019). Updated European Consensus Statement on diagnosis and treatment of adult ADHD. European Psychiatry, 56, 14-34. https://doi.org/10.1016/j.eurpsy.2018.11.001

@article{f4f56279c63b4538b984390843400ba7,

title = "Updated European Consensus Statement on diagnosis and treatment of adult ADHD",

abstract = "Background Attention-deficit/hyperactivity disorder (ADHD) is among the most common psychiatric disorders of childhood that often persists into adulthood and old age. Yet ADHD is currently underdiagnosed and undertreated in many European countries, leading to chronicity of symptoms and impairment, due to lack of, or ineffective treatment, and higher costs of illness. Methods The European Network Adult ADHD and the Section for Neurodevelopmental Disorders Across the Lifespan (NDAL) of the European Psychiatric Association (EPA), aim to increase awareness and knowledge of adult ADHD in and outside Europe. This Updated European Consensus Statement aims to support clinicians with research evidence and clinical experience from 63 experts of European and other countries in which ADHD in adults is recognized and treated. Results Besides reviewing the latest research on prevalence, persistence, genetics and neurobiology of ADHD, three major questions are addressed: (1) What is the clinical picture of ADHD in adults? (2) How should ADHD be properly diagnosed in adults? (3) How should adult ADHDbe effectively treated? Conclusions ADHD often presents as a lifelong impairing condition. The stigma surrounding ADHD, mainly due to lack of knowledge, increases the suffering of patients. Education on the lifespan perspective, diagnostic assessment, and treatment of ADHD must increase for students of general and mental health, and for psychiatry professionals. Instruments for screening and diagnosis of ADHD in adults are available, as are effective evidence-based treatments for ADHD and its negative outcomes. More research is needed on gender differences, and in older adults with ADHD.",

keywords = "Adult ADHD, Diagnosis, EPA, European Network Adult ADHD, Treatment, Updated European Consensus Statement",

author = "Kooij, {J. J.S.} and D. Bijlenga and L. Salerno and R. Jaeschke and I. Bitter and J. Bal{\'a}zs and J. Thome and G. Dom and S. Kasper and {Nunes Filipe}, C. and S. Stes and P. Mohr and S. Lepp{\"a}m{\"a}ki and {Casas Brugu{\'e}}, M. and J. Bobes and Mccarthy, {J. M.} and V. Richarte and {Kjems Philipsen}, A. and A. Pehlivanidis and A. Niemela and B. Styr and B. Semerci and B. Bolea-Alamanac and D. Edvinsson and D. Baeyens and D. Wynchank and E. Sobanski and A. Philipsen and F. McNicholas and H. Caci and I. Mihailescu and I. Manor and I. Dobrescu and J. Krause and J. Fayyad and Ramos-Quiroga, {J. A.} and K. Foeken and F. Rad and M. Adamou and M. Ohlmeier and M. Fitzgerald and M. Gill and M. Lensing and {Motavalli Mukaddes}, N. and P. Brudkiewicz and P. Gustafsson and P. Tani and P. Oswald and Carpentier, {P. J.} and {De Rossi}, P. and R. Delorme and {Markovska Simoska}, S. and S. Pallanti and S. Young and S. Bejerot and T. Lehtonen and J. Kustow and U. M{\"u}ller-Sedgwick and T. Hirvikoski and V. Pironti and Y. Ginsberg and Z. F{\'e}legeh{\'a}zy and Garcia-Portilla, {M. P.} and P. Asherson",

note = "Publisher Copyright: {\textcopyright} 2018 The Author(s)",

year = "2019",

month = feb,

doi = "10.1016/j.eurpsy.2018.11.001",

language = "English",

volume = "56",

pages = "14--34",

journal = "European Psychiatry",

issn = "0924-9338",

publisher = "Cambridge University Press",

}

Kooij, JJS, Bijlenga, D, Salerno, L, Jaeschke, R, Bitter, I, Balázs, J, Thome, J, Dom, G, Kasper, S, Nunes Filipe, C, Stes, S, Mohr, P, Leppämäki, S, Casas Brugué, M, Bobes, J, Mccarthy, JM, Richarte, V, Kjems Philipsen, A, Pehlivanidis, A, Niemela, A, Styr, B, Semerci, B, Bolea-Alamanac, B, Edvinsson, D, Baeyens, D, Wynchank, D, Sobanski, E, Philipsen, A, McNicholas, F, Caci, H, Mihailescu, I, Manor, I, Dobrescu, I, Krause, J, Fayyad, J, Ramos-Quiroga, JA, Foeken, K, Rad, F, Adamou, M, Ohlmeier, M, Fitzgerald, M, Gill, M, Lensing, M, Motavalli Mukaddes, N, Brudkiewicz, P, Gustafsson, P, Tani, P, Oswald, P, Carpentier, PJ, De Rossi, P, Delorme, R, Markovska Simoska, S, Pallanti, S, Young, S, Bejerot, S, Lehtonen, T, Kustow, J, Müller-Sedgwick, U, Hirvikoski, T, Pironti, V, Ginsberg, Y, Félegeházy, Z, Garcia-Portilla, MP & Asherson, P 2019, 'Updated European Consensus Statement on diagnosis and treatment of adult ADHD', European Psychiatry, vol. 56, pp. 14-34. https://doi.org/10.1016/j.eurpsy.2018.11.001

TY - JOUR

T1 - Updated European Consensus Statement on diagnosis and treatment of adult ADHD

AU - Kooij, J. J.S.

AU - Bijlenga, D.

AU - Salerno, L.

AU - Jaeschke, R.

AU - Bitter, I.

AU - Balázs, J.

AU - Thome, J.

AU - Dom, G.

AU - Kasper, S.

AU - Nunes Filipe, C.

AU - Stes, S.

AU - Mohr, P.

AU - Leppämäki, S.

AU - Casas Brugué, M.

AU - Bobes, J.

AU - Mccarthy, J. M.

AU - Richarte, V.

AU - Kjems Philipsen, A.

AU - Pehlivanidis, A.

AU - Niemela, A.

AU - Styr, B.

AU - Semerci, B.

AU - Bolea-Alamanac, B.

AU - Edvinsson, D.

AU - Baeyens, D.

AU - Wynchank, D.

AU - Sobanski, E.

AU - Philipsen, A.

AU - McNicholas, F.

AU - Caci, H.

AU - Mihailescu, I.

AU - Manor, I.

AU - Dobrescu, I.

AU - Krause, J.

AU - Fayyad, J.

AU - Ramos-Quiroga, J. A.

AU - Foeken, K.

AU - Rad, F.

AU - Adamou, M.

AU - Ohlmeier, M.

AU - Fitzgerald, M.

AU - Gill, M.

AU - Lensing, M.

AU - Motavalli Mukaddes, N.

AU - Brudkiewicz, P.

AU - Gustafsson, P.

AU - Tani, P.

AU - Oswald, P.

AU - Carpentier, P. J.

AU - De Rossi, P.

AU - Delorme, R.

AU - Markovska Simoska, S.

AU - Pallanti, S.

AU - Young, S.

AU - Bejerot, S.

AU - Lehtonen, T.

AU - Kustow, J.

AU - Müller-Sedgwick, U.

AU - Hirvikoski, T.

AU - Pironti, V.

AU - Ginsberg, Y.

AU - Félegeházy, Z.

AU - Garcia-Portilla, M. P.

AU - Asherson, P.

PY - 2019/2

Y1 - 2019/2

N2 - Background Attention-deficit/hyperactivity disorder (ADHD) is among the most common psychiatric disorders of childhood that often persists into adulthood and old age. Yet ADHD is currently underdiagnosed and undertreated in many European countries, leading to chronicity of symptoms and impairment, due to lack of, or ineffective treatment, and higher costs of illness. Methods The European Network Adult ADHD and the Section for Neurodevelopmental Disorders Across the Lifespan (NDAL) of the European Psychiatric Association (EPA), aim to increase awareness and knowledge of adult ADHD in and outside Europe. This Updated European Consensus Statement aims to support clinicians with research evidence and clinical experience from 63 experts of European and other countries in which ADHD in adults is recognized and treated. Results Besides reviewing the latest research on prevalence, persistence, genetics and neurobiology of ADHD, three major questions are addressed: (1) What is the clinical picture of ADHD in adults? (2) How should ADHD be properly diagnosed in adults? (3) How should adult ADHDbe effectively treated? Conclusions ADHD often presents as a lifelong impairing condition. The stigma surrounding ADHD, mainly due to lack of knowledge, increases the suffering of patients. Education on the lifespan perspective, diagnostic assessment, and treatment of ADHD must increase for students of general and mental health, and for psychiatry professionals. Instruments for screening and diagnosis of ADHD in adults are available, as are effective evidence-based treatments for ADHD and its negative outcomes. More research is needed on gender differences, and in older adults with ADHD.

AB - Background Attention-deficit/hyperactivity disorder (ADHD) is among the most common psychiatric disorders of childhood that often persists into adulthood and old age. Yet ADHD is currently underdiagnosed and undertreated in many European countries, leading to chronicity of symptoms and impairment, due to lack of, or ineffective treatment, and higher costs of illness. Methods The European Network Adult ADHD and the Section for Neurodevelopmental Disorders Across the Lifespan (NDAL) of the European Psychiatric Association (EPA), aim to increase awareness and knowledge of adult ADHD in and outside Europe. This Updated European Consensus Statement aims to support clinicians with research evidence and clinical experience from 63 experts of European and other countries in which ADHD in adults is recognized and treated. Results Besides reviewing the latest research on prevalence, persistence, genetics and neurobiology of ADHD, three major questions are addressed: (1) What is the clinical picture of ADHD in adults? (2) How should ADHD be properly diagnosed in adults? (3) How should adult ADHDbe effectively treated? Conclusions ADHD often presents as a lifelong impairing condition. The stigma surrounding ADHD, mainly due to lack of knowledge, increases the suffering of patients. Education on the lifespan perspective, diagnostic assessment, and treatment of ADHD must increase for students of general and mental health, and for psychiatry professionals. Instruments for screening and diagnosis of ADHD in adults are available, as are effective evidence-based treatments for ADHD and its negative outcomes. More research is needed on gender differences, and in older adults with ADHD.

KW - Adult ADHD

KW - Diagnosis

KW - EPA

KW - European Network Adult ADHD

KW - Treatment

KW - Updated European Consensus Statement

UR - http://www.scopus.com/inward/record.url?scp=85056845323&partnerID=8YFLogxK

U2 - 10.1016/j.eurpsy.2018.11.001

DO - 10.1016/j.eurpsy.2018.11.001

M3 - Article

C2 - 30453134

AN - SCOPUS:85056845323

SN - 0924-9338

VL - 56

SP - 14

EP - 34

JO - European Psychiatry

JF - European Psychiatry

ER -

Updated European Consensus Statement on diagnosis and treatment of adult ADHD

Abstract

Keywords

Access to Document

Fingerprint

Cite this